AI-generated analysis. Always verify with the original filing.
VolitionRx Limited filed an 8-K on February 20, 2026, disclosing under Item 3.02 an unregistered sale of equity securities pursuant to a securities purchase agreement dated May 15, 2025, as amended and restated. The filing references Exhibit 104 as the cover page interactive data file.
Event Type
Disclosure
Mandatory
Variant
8-K
Unregistered Sales of Equity Securities As previously reported, pursuant to that certain securities purchase agreement dated May 15, 2025 (as amended and restat
. Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2